Journal Article DKFZ-2017-02919

http://join2-wiki.gsi.de/foswiki/pub/Main/Artwork/join2_logo100x88.png
Melanotic tumors of the nervous system are characterized by distinct mutational, chromosomal and epigenomic profiles.

 ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;

2015
Wiley-Blackwell Oxford

Brain pathology 25(2), 202 - 208 () [10.1111/bpa.12228]
 GO

This record in other databases:  

Please use a persistent id in citations: doi:

Abstract: Melanotic tumors of the nervous system show overlapping histological characteristics but differ substantially in their biological behavior. In order to achieve a better delineation of such tumors, we performed an in-depth molecular characterization. Eighteen melanocytomas, 12 melanomas, and 14 melanotic and 14 conventional schwannomas (control group) were investigated for methylome patterns (450k array), gene mutations associated with melanotic tumors and copy number variants (CNVs). The methylome fingerprints assigned tumors to entity-specific groups. Methylation groups also showed a substantial overlap with histology-based diagnosis suggesting that they represent true biological entities. On the molecular level, melanotic schwannomas were characterized by a complex karyotype with recurrent monosomy of chromosome 22q and variable whole chromosomal gains and recurrent losses commonly involving chromosomes 1, 17p and 21. Melanocytomas carried GNAQ/11 mutations and presented with CNV involving chromosomes 3 and 6. Melanomas were frequently mutated in the TERT promoter, harbored additional oncogene mutations and showed recurrent chromosomal losses involving chromosomes 9, 10 and 6q, as well as gains of 22q. Together, melanotic nervous system tumors have several distinct mutational and chromosomal alterations and can reliably be distinguished by methylome profiling.

Classification:

Contributing Institute(s):
  1. KKE Neuropathologie (G380)
  2. Molekulare Genetik (B060)
  3. Pädiatrische Neuroonkologie (B062)
  4. DKTK Heidelberg (L101)
  5. DKTK Frankfurt (L501)
Research Program(s):
  1. 317 - Translational cancer research (POF3-317) (POF3-317)

Appears in the scientific report 2015
Database coverage:
Medline ; BIOSIS Previews ; Current Contents - Life Sciences ; IF >= 5 ; JCR ; NCBI Molecular Biology Database ; SCOPUS ; Science Citation Index ; Science Citation Index Expanded ; Thomson Reuters Master Journal List ; Web of Science Core Collection
Click to display QR Code for this record

The record appears in these collections:
Document types > Articles > Journal Article
Public records
Publications database

 Record created 2017-09-21, last modified 2024-02-28



Rate this document:

Rate this document:
1
2
3
 
(Not yet reviewed)